Ming Yue Li

Ming Yue Li

Auto-generated profile, based on publicly available information

Ming Yue Li

Heilongjiang University of Chinese Medicine, 24 Heping Road, Xiangfang District, Harbin, 150036, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XSXiaowei Sun
Xiaowei Sun
MLMingyue Li
Mingyue Li
QLQuan Li
Quan Li
HYHongna Yin
Hongna Yin
XJXicheng Jiang
Xicheng Jiang
TYTiansong Yang
Tiansong Yang
Brain‐computer interfaces (BCIs), a new type of rehabilitation technology, pick up nerve cell signals, identify and classify their activities, and convert them into computer‐recognized instructions. This technique has been widely used in the rehabilitation of stroke patients in recent years and appears to promote motor function recovery after stroke. At present, the application of BCI in poststroke cognitive impairment is increasing, which is a common complication that also affects the rehabilitation process. This paper reviews the promise and potential drawbacks of using BCI to treat poststroke cognitive impairment, providing a solid theoretical basis for the application of BCI in this area.

26 April 2021 in Research Square
Verified
Preprint
Open access
PDF file
MLMing Yue Li
Ming Yue Li
XDXiaohong Dai
Xiaohong Dai
XYXueping Yu
Xueping Yu
WZWei Zou
Wei Zou
WTWei Teng
Wei Teng
XWXin Wen
Xin Wen
Intracerebral hemorrhage (ICH) is a devastating disease and different patients have varying degrees of neurological impairment despite after treatment. However, the therapeutic strategies targeting currently known cell death pathways of the secondary injury fail to effectively improve neurological deficits after ICH. As a new form of cell death, ferroptosis is closely related to neurological deficits after ICH. Moreover, increasing evidence has shown that scalp acupuncture (SA) has a neuroprotective effect on ICH rats by mediating different molecular pathways. Our study sought to investigate the effect of SA treatment on neurological function and elucidate whether SA could alleviate secondary injury after ICH by regulating ferroptosis, alongside analyzing its underlying mechanisms. First, our results demonstrated that SA treatment (Baihui [DU20] acupoint-penetrating-Qubin [GB7] acupoint, on the lesion side) could attenuate neurological functional impairment in ICH rats, according to the Ludmila Belayev test, and improve pathological injury according to hematoxylin-eosin staining. Second, perihematomal brain tissues from different groups were collected to detect the biological characteristics of neuronal ferroptosis including iron overload, lipid peroxidation accumulation, mitochondrial morphology changes and the decreased NeuN expression levels. Results revealed that SA treatment could attenuate neuronal ferroptosis in ICH rats to a remarkable degree. Furthermore, consistent with deferoxamine (DFX) being one of the main inhibitors of ferroptosis, there were no significant differences between the effects of SA treatment and DFX administration. The molecular mechanism studies found that SA treatment triggered the antioxidant effect alongside activating the p62/Keap1/Nrf2 pathway and up-regulating levels of ferritin heavy chain 1 (FTH1) and glutathione peroxidase 4 (GPX4), which contributed to reduced iron overload and oxidative stress in ICH rats. These results suggest that the p62/Keap1/Nrf2 signaling pathway is responsible for alleviating ferroptosis lipid peroxidation injury after ICH, thereby providing new theoretical basis with regards to SA treatment of ICH.